我问下，那里可以买？_老虎社区_美港股上老虎 - 老虎社区

我问下，那里可以买？谢谢

异动解读 | 礼来口服减肥新药临床成功，股价盘中暴涨14.25%

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":425554726552008,"tweetId":"425554726552008","gmtCreate":1744905263281,"gmtModify":1744905265181,"author":{"id":3500646460202211,"idStr":"3500646460202211","authorId":3500646460202211,"authorIdStr":"3500646460202211","name":"七风哥哥","avatar":"https://static.tigerbbs.com/995231888a039cddd9f2f0ecf7b865b0","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":8,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.14","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>我问下，那里可以买？谢谢</p></body></html>","htmlText":"<html><head></head><body><p>我问下，那里可以买？谢谢</p></body></html>","text":"我问下，那里可以买？谢谢","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/425554726552008","repostId":1166346461,"repostType":2,"repost":{"id":"1166346461","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"异动解读","id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1744896911,"share":"https://www.laohu8.com/m/news/1166346461?lang=&edition=full","pubTime":"2025-04-17 21:35","market":"nz","language":"zh","title":"异动解读 | 礼来口服减肥新药临床成功，股价盘中暴涨14.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166346461","media":"异动解读","summary":"礼来公司股价今日盘中大涨14.25%，引发市场广泛关注。这一显著涨幅源于公司宣布其口服减肥药Orforglipron在3期临床试验中取得积极成果。礼来公司表示，对于在全球推出Orforglipron而不受供应限制的能力充满信心。分析师普遍看好礼来的发展前景，认为该公司在快速增长的减肥药市场中占据有利地位。随着肥胖症和相关健康问题的日益普遍，市场对有效且便捷的减肥解决方案的需求持续增长，这可能为礼来带来可观的收入增长。","content":"<p>礼来（Eli Lilly）公司股价今日盘中大涨14.25%，引发市场广泛关注。这一显著涨幅源于公司宣布其口服减肥药Orforglipron在3期临床试验中取得积极成果。</p>\n\n<p>根据礼来公司的声明，Orforglipron是第一个成功完成3期试验的口服小分子胰高血糖素样肽-1（GLP-1）受体激动剂，无需饮食和水限制。在最高剂量下，参与试验的2型糖尿病患者平均减重7.9%，约16磅（7.3公斤）。此外，该药物还显示出改善血糖控制的效果，不同剂量组的糖化血红蛋白（HbA1c）水平平均下降了1.3%至1.6%。</p>\n\n<p>这一突破性进展意义重大。与目前市场上流行的注射型减肥药相比，口服药物被视为更便捷的选择，可能会大大提高患者的依从性。礼来公司表示，对于在全球推出Orforglipron而不受供应限制的能力充满信心。分析师普遍看好礼来的发展前景，认为该公司在快速增长的减肥药市场中占据有利地位。随着肥胖症和相关健康问题的日益普遍，市场对有效且便捷的减肥解决方案的需求持续增长，这可能为礼来带来可观的收入增长。</p>","source":"ai_movement_cn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | 礼来口服减肥新药临床成功，股价盘中暴涨14.25%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | 礼来口服减肥新药临床成功，股价盘中暴涨14.25%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-04-17 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>礼来（Eli Lilly）公司股价今日盘中大涨14.25%，引发市场广泛关注。这一显著涨幅源于公司宣布其口服减肥药Orforglipron在3期临床试验中取得积极成果。</p>\n\n<p>根据礼来公司的声明，Orforglipron是第一个成功完成3期试验的口服小分子胰高血糖素样肽-1（GLP-1）受体激动剂，无需饮食和水限制。在最高剂量下，参与试验的2型糖尿病患者平均减重7.9%，约16磅（7.3公斤）。此外，该药物还显示出改善血糖控制的效果，不同剂量组的糖化血红蛋白（HbA1c）水平平均下降了1.3%至1.6%。</p>\n\n<p>这一突破性进展意义重大。与目前市场上流行的注射型减肥药相比，口服药物被视为更便捷的选择，可能会大大提高患者的依从性。礼来公司表示，对于在全球推出Orforglipron而不受供应限制的能力充满信心。分析师普遍看好礼来的发展前景，认为该公司在快速增长的减肥药市场中占据有利地位。随着肥胖症和相关健康问题的日益普遍，市场对有效且便捷的减肥解决方案的需求持续增长，这可能为礼来带来可观的收入增长。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166346461","content_text":"礼来（Eli Lilly）公司股价今日盘中大涨14.25%，引发市场广泛关注。这一显著涨幅源于公司宣布其口服减肥药Orforglipron在3期临床试验中取得积极成果。\n根据礼来公司的声明，Orforglipron是第一个成功完成3期试验的口服小分子胰高血糖素样肽-1（GLP-1）受体激动剂，无需饮食和水限制。在最高剂量下，参与试验的2型糖尿病患者平均减重7.9%，约16磅（7.3公斤）。此外，该药物还显示出改善血糖控制的效果，不同剂量组的糖化血红蛋白（HbA1c）水平平均下降了1.3%至1.6%。\n这一突破性进展意义重大。与目前市场上流行的注射型减肥药相比，口服药物被视为更便捷的选择，可能会大大提高患者的依从性。礼来公司表示，对于在全球推出Orforglipron而不受供应限制的能力充满信心。分析师普遍看好礼来的发展前景，认为该公司在快速增长的减肥药市场中占据有利地位。随着肥胖症和相关健康问题的日益普遍，市场对有效且便捷的减肥解决方案的需求持续增长，这可能为礼来带来可观的收入增长。","news_type":1},"isVote":1,"tweetType":1,"viewCount":222,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":22,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/425554726552008"}